LFVN
Lifevantage Corp
Nasdaq Pharmaceutical Preparations Accelerated filer
Smaller reporting company

Key Financials

Gross Profit
$183.7M
↑ 15.7%
Revenue
$228.5M
↑ 14.2%
Operating Income
$12.2M
↑ 181.6%
Net Income
$9.8M
↑ 233.8%
Total Assets
$72.0M
↑ 19.3%
EPS (Diluted)
$0.75
↑ 226.1%
Total Liabilities
$37.3M
↑ 8.8%
Shareholders' Equity
$34.6M
↑ 33.3%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 8/13/2026 View on SEC
4 8/10/2026 View on SEC
3 8/10/2026 View on SEC
S-8 8/3/2026 View on SEC
8-K 8/3/2026 View on SEC
SCHEDULE 13G/A 7/29/2026 View on SEC
4 7/6/2026 View on SEC
4 7/6/2026 View on SEC
4 7/6/2026 View on SEC
SCHEDULE 13G/A 7/6/2026 View on SEC

Company Information

Field Value
Ticker LFVN
Company Name Lifevantage Corp
CIK 849146
Sector Pharmaceutical Preparations
Industry Accelerated filer
Smaller reporting company
Exchange Nasdaq
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 0630
Phone 801-432-9000